AaviGen commits €17 million to research into precision gene therapy for heart failure
The biotechnology company AaviGen is providing €17 million in a second round of funding to advance precision gene therapies for heart failure into the…
New therapeutic approach for broken heart syndrome
Research on Takotsubo syndrome, also known as broken heart syndrome / Heart researchers at Heidelberg University investigate an inflammatory signaling…